Entrada Therapeutics Reports Second Quarter 2026 Financial Results

Go back to Entrada Therapeutics Reports Second Quarter 2026 Financial Results
(NASDAQ: TRDA) Delayed: 7.49 -0.11 (1.45%)
Previous Close $7.60    52 Week High
Open $7.64    52 Week Low
Day High $7.74    P/E N/A 
Day Low $7.49    EPS
Volume 41,815